Skip to main content
Clinical Trials/NL-OMON44586
NL-OMON44586
Withdrawn
Not Applicable

Intra-articular injection of stromal vascular fraction from adipose tissue in osteoartritis of the temporomandibular joint - SVF injection in TMJ

niversitair Medisch Centrum Groningen0 sites20 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
20
Status
Withdrawn
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age between 18\-60 years;Pain in the TMJ region;Pain still present after two weeks of ibuprofen 600 mg three times daily (exclusion of acute inflammatory pain) ;Pain disappears after intra\-articular injection (Ultracain forte, Aventis Pharma, Hoevelaken, The Netherlands) ;Pain still present (VAS during movement more than 20mm) after 3 weeks after an initial arthrocentesis.

Exclusion Criteria

  • Systemic rheumatic disease ;Bony ankylosis of the TMJ ;Incompetence to speak the Dutch or English language ;Pregnancy ;Concurrent use of anti\-inflammatory medication, steroids, muscle relaxants or antidepressants ;Unwillingness to receive one of the study treatments ;Prior open TMJ surgery ;Prior to liposuction;Coagulation disorders;BMI \>18 ;BMI \>25;Abnormalities in bloodanalysis

Outcomes

Primary Outcomes

Not specified

Similar Trials